Jellagen signs Research Partnership Agreement with IFREMER – The French Institute of Research and Marine Exploitation
Ifremer is recognized throughout the world as one of the very first institutes in marine science and technology
READ POSTBlog
Infographic: Enhance & Simplify your 3D Cell Culture with JellaGel™
Discover how JellaGel compares to Matrigel & how it can successfully support Mouse Embryonic Stem Cells (mESCs)
READ POSTInfographic: Cancer Spheroids on JellaGel™
Discover how JellaGel can help simplify and improve your cancer spheroid research
READ POSTWhat is ISO 13485?
ISO 13485 is a Quality Management System (QMS) standard taken from the internationally recognized ISO 9000 quality management standard series.
READ POSTJellagen launches JellaGel™
The first Collagen Type 0 Hydrogel taking on the market leading Extracellular Matrix.
READ POSTJellagen Boosts Scientific Advisory Board with New Appointments Dr Mike Barbeck and Dr Andy Weymann
Jellagen announces the appointments of Dr Mike Barbeck and Dr Andy Weymann to the Scientific Advisory Board
READ POSTJellagen on the BBC World Service
Jellagen were visited by the BBC who wanted to talk to us about our jellyfish collagen and the opportunities it creates
READ POSTJellagen® extends coverage in Asia Pacific with new distributor agreements
The companies will act as exclusive distributors of Jellagen’s products and services across their respective regions of India and South Korea.
READ POSTJellagen® announces collaboration with Mayo Clinic
jellagen has entered into a license agreement for an exclusive grant to patent rights with Mayo Clinic for the development in treatment of vocal cord paralysis.
READ POSTNew Research Paper: Biological Evaluation of Jellyfish Collagen as a New Research Tool for the Growth and Culture of iPSC Derived Microglia
Microglia Cells on Jellagen® demonstrated a more ramified “microglial-like” cell morphology compared to cells cultured on mammalian Rat Tail Collagen I and Laminin-511
READ POST
